Treating Biofilm Infections.
Biofilm infections do not respond well to conventional antibiotics and can result in chronic infections. There are currently no approved drugs to treat bacterial biofilms. Our peptides address the fast growing and unmet medical need for new treatment options for patients suffering from difficult to treat biofilm infections due to antimicrobial resistance.

Immunomodulatory Agents.
ABT Immunomodulatory Peptides have been particularly designed to enhance the anti-inflammatory activity of synthetic IDR peptides to mitigate the damaging effects of excessive inflammation that can accompany infections or other immune disorders.